Can individualized sunitinib dose and schedule changes optimize outcomes for kidney cancer patients?

  • Georg A. Bjarnason

Abstract

The recommended starting dose and schedule for sunitinib is 50 mg daily for 28 days, followed by a 14-day break with significant dose reductions to 37.5 mg (75% of starting dose), and then 25 mg (50% of starting dose) on the same schedule (four/two schedule). There are several reasons why these dose and scheduling recommendations may not be optimal for most patients, as outlined below.
Published
2016-12-15
How to Cite
Bjarnason, G. A. (2016). Can individualized sunitinib dose and schedule changes optimize outcomes for kidney cancer patients?. Canadian Urological Association Journal, 10(11-12), S252-5. https://doi.org/10.5489/cuaj.4293
Section
Supplement-Review